Masaru Matsuda, See Remarks at Arcutis Biotherapeutics, Inc. (ARQT), bought 5,657 shares at $7.11 ($19K) on 2024-11-30, disclosed to the SEC on 2024-12-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.69 | 4,000 | $7K | 36.5% |
| 2 | $7.11 | 1,657 | $12K | 63.5% |
| Total | $3.28 avg | 5,657 | $19K | 100% |
| Filing → |
| ARQT | SELL | 2026-08-05 | $32K | — | Filing → |
| ARQT | SELL | 2026-05-06 | $192K | — | Filing → |
| ARQT | SELL | 2026-03-03 | $314K | — | Filing → |